Bayer AG (BAYN) PT Set at €124.00 by Deutsche Bank AG
Bayer AG (FRA:BAYN) received a €124.00 ($145.88) price objective from Deutsche Bank AG in a report released on Friday. The firm currently has a “buy” rating on the healthcare company’s stock.
Several other equities research analysts also recently commented on BAYN. Citigroup Inc. set a €130.00 ($152.94) price objective on Bayer AG and gave the company a “buy” rating in a report on Thursday, June 29th. Sanford C. Bernstein set a €128.00 ($150.59) price objective on Bayer AG and gave the company a “buy” rating in a report on Friday, June 30th. DZ Bank AG reissued a “neutral” rating on shares of Bayer AG in a report on Friday, June 30th. Goldman Sachs Group, Inc. (The) set a €125.00 ($147.06) price objective on Bayer AG and gave the company a “buy” rating in a report on Friday, June 30th. Finally, Berenberg Bank set a €121.00 ($142.35) price objective on Bayer AG and gave the company a “neutral” rating in a report on Monday, July 3rd. Eight investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. Bayer AG currently has an average rating of “Buy” and an average target price of €122.24 ($143.81).
Bayer AG (FRA BAYN) opened at 111.925 on Friday. The stock has a 50 day moving average of €114.09 and a 200-day moving average of €112.90. Bayer AG has a 52-week low of €85.72 and a 52-week high of €123.83. The company has a market cap of €97.61 billion and a price-to-earnings ratio of 19.361.
Bayer AG Company Profile
Receive News & Ratings for Bayer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer AG and related companies with MarketBeat.com's FREE daily email newsletter.